Sat10192019

Robins Global News & Noticias



  • Gaming Chair Review
    Gaming Chair Review
  • Writing Service Review
    Writing Service Review
  • Microsoft Exam
    Microsoft Exam
  • Youtube Marketing Guide
    Youtube Marketing Guide
  • Slot Game Review
    Slot Game Review
  • All Elite Wrestling
    All Elite Wrestling

RobinsPost News Network

+ Larger Font | + Smaller Font

Consumer Daily Reports

Consumer News: AurobindoPharma USA recalls Amlodipine Valsartan and Valsartan tablets

PhotoAurobindoPharma USA and Acetris Health are expanding an earlier recall of Valsartan and Amlodipine and Valsartan tablets, which are used to control high blood pressure and for the treatment of heart failure.

Trace amounts of an unexpected impurity, N-nitrosodiethylamine (NDEA) -- a probable human carcinogen – have been found in the product.

The following products, packaged in bottles, are being recalled:

NDC Name and strength Count Lot number Expiry

ACETRIS LOTS

52343-122-30 Valsartan Tablets USP 40mg 30 470170038A 19-Oct
52343-122-30 Valsartan Tablets USP 40mg 30 470180010A 20-Feb
52343-122-30 Valsartan Tablets USP 40mg 30 470180012A 20-Mar
52343-123-90 Valsartan Tablets USP 80mg 90 471170019A 19-Oct
52343-123-90 Valsartan Tablets USP 80mg 90 471180006A 20-Mar
52343-123-90 Valsartan Tablets USP 80mg 90 471180007A 20-Mar
52343-123-90 Valsartan Tablets USP 80mg 90 471180016A 20-May
52343-124-90 Valsartan Tablets USP 160mg 90 472180005B 20-Feb
52343-124-90 Valsartan Tablets USP 160mg 90 472180011A 20-Apr
52343-124-90 Valsartan Tablets USP 160mg 90 472180012A 20-Apr
52343-125-90 Valsartan Tablets USP 320mg 90 473180007A 20-Mar
52343-125-90 Valsartan Tablets USP 320mg 90 473180008A 20-Mar
52343-125-90 Valsartan Tablets USP 320mg 90 473180011A 20-Apr
52343-125-90 Valsartan Tablets, USP 320mg 90 473180020B1 20-Jul
52343-125-90 Valsartan Tablets, USP 320mg 90 473170019B 19-Oct

AUROBINDO LOTS

65862-570-30 Valsartan Tablets USP 40mg 30 470180008A 20-Feb
65862-570-30 Valsartan Tablets USP 40mg 30 470180014A 20-Mar
65862-570-30 Valsartan Tablets USP 40mg 30 470180016A 20-Mar
65862-571-90 Valsartan Tablets USP 80mg 90 471170015A 19-Sep
65862-571-90 Valsartan Tablets USP 80mg 90 471180004A 20-Feb
65862-571-90 Valsartan Tablets USP 80mg 90 471180005A 20-Feb
65862-572-90 Valsartan Tablets USP 160mg 90 472180001A 20-Jan
65862-572-90 Valsartan Tablets USP 160mg 90 472180002A 20-Jan
65862-572-90 Valsartan Tablets USP 160mg 90 472180003A 20-Jan
65862-572-90 Valsartan Tablets USP 160mg 90 472180004A 20-Jan
65862-572-90 Valsartan Tablets USP 160mg 90 472180007A 20-Mar
65862-572-90 Valsartan Tablets USP 160mg 90 472180008A 20-Mar
65862-572-90 Valsartan Tablets USP 160mg 90 472180009A 20-Mar
65862-572-90 Valsartan Tablets USP 160mg 90 472180010A 20-Mar
65862-572-90 Valsartan Tablets USP 160mg 90 472180013A 20-Apr
65862-572-90 Valsartan Tablets USP 160mg 90 472180014A 20-Apr
65862-573-90 Valsartan Tablets USP 320mg 90 473180004A 20-Feb
65862-573-90 Valsartan Tablets USP 320mg 90 473180005A 20-Feb
65862-573-90 Valsartan Tablets USP 320mg 90 473180006A 20-Mar
65862-573-90 Valsartan Tablets USP 320mg 90 473180017A 20-May
65862-739-30 Amlodipine and Valsartan Tablets USP10mg/160mg 30 VFSA17007-A 19-Oct
65862-570-30 Valsartan Tablets, USP 40mg 30 470180032A 20-May
65862-573-90 Valsartan Tablets, USP 320mg 90 473170019A 19-Oct
65862-573-90 Valsartan Tablets, USP 320mg 90 473180016A

The recalled products were distributed nationwide.

What to do

Patients should continue taking their medication, as the risk of harm to their health may be higher if the treatment is stopped immediately without any alternative treatment. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.

AurobindoPharma is notifying its customers by phone and in writing and arranging for return of all recalled products. Instructions for returning recalled products are given in the recall letter.

Consumers with medical questions regarding this recall may contact AurobindoPharma at (866) 850- 2876, Option 2 or by email at This email address is being protected from spambots. You need JavaScript enabled to view it..



Posted: 2019-03-13 13:50:35

Get Full News Story On Consumer Affairs


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.


Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Consumer News: AurobindoPharma USA recalls Amlodipine Valsartan and Valsartan tablets | Consumer Daily Reports | RobinsPost News Network - Newscast

AurobindoPharma USA recalls Amlodipine Valsartan and Valsartan tablets

Wed, 13 Mar 2019 06:56:00 GMT

AurobindoPharma USA and Acetris Health are expanding an earlier recall of Valsartan and Amlodipine and Valsartan tablets, which are used to control ... Option 2 or by email at pvg@aurobindousa.com.

Recall alert: Losartan, valsartan, amlodipine and valsartan tablets recalls expanded

Mon, 04 Mar 2019 09:13:00 GMT

Two pharmaceutical companies are expanding the recent recalls of a variety of blood pressure ... AurobindoPharma USA has expanded its recall of valsartan and amlodipine and valsartan tablets to 38 ...

Recall alert: Losartan, valsartan, amlodipine and valsartan tablets recalls expanded

Mon, 04 Mar 2019 09:11:00 GMT

All of the recalls are due to the finding of N-Methylnitrosobutyric ... AurobindoPharma USA has expanded its recall of valsartan and amlodipine and valsartan tablets to 38 additional lots after the ...

Aurobindo Pharma USA recalls 38 lots of Amlodipine Valsartan, Valsartan tablets

Sat, 02 Mar 2019 02:11:00 GMT

Aurobindo Phrama USA has initiated a voluntary nationwide consumer level recall expansion of 38 lots of Amlodipine Valsartan tablets USP and Valsartan Tablets, USP due to the detection of NDEA ...

Teva Recalls All Amlodipine/Valsartan Combination Products in US

Tue, 27 Nov 2018 15:04:00 GMT

Teva Pharmaceuticals has recalled all lots of amlodipine/valsartan combination tablets and amlodipine/valsartan/hydrochlorothiazide combination tablets in the United ...

Related News Story Videos From Youtube

FDA expands recall on blood pressure drug valsartan due to probable carcinogen


Related Videos On: FDA expands recall on blood pressure drug valsartan due to probable carcinogen


Valsartan blood pressure drug recall expands


Related Videos On: Valsartan blood pressure drug recall expands


National News FDA recalls blood pressure medication that could cause cancer


Related Videos On: National News FDA recalls blood pressure medication that could cause cancer


More blood pressure pills recalled for cancer concerns


Related Videos On: More blood pressure pills recalled for cancer concerns


Blood pressure medicine recall expands


Related Videos On: Blood pressure medicine recall expands







Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2019 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.